|
2025 Conference Publication Prognostic Implications Of Platelet FCγRIIA During The First Year After Myocardial InfarctionSchneider, David J., McMahon, Sean Robert, Angiolillo, Dominick J., Fanaroff, Alexander C., Wanamaker, Brett, Ibrahim, Homam, Effron, Mark B., Hohl, Patrick Kennedy, Shapiro, Timothy Alan, Ball, Kevin M. and DiBattiste, Peter M. (2025). Prognostic Implications Of Platelet FCγRIIA During The First Year After Myocardial Infarction. ACC.25, Chicago, IL United States, 29-31 March 2025. San Diego, CA United States: Elsevier. doi: 10.1016/s0735-1097(25)02269-7 |
|
2024 Conference Publication Health System Variability in Lipid Management for Patients with Atherosclerotic Cardiovascular Disease: An Analysis from Cv-MOBIUSShah, Nishant, Shrader, Peter, Shoji, Satoshi, Martin, Seth, Fernandez, Soledad, Chamberlain, Alanna, Arnold, Jonathan, Shapiro, Michael, Effron, Mark, Chrischilles, Elizabeth, Allred, Clint, Priest, Elisa, Syed, Mahanaz, Kirchner, H Lester, Leja, Monika, Ahmad, Zahid, Kalich, Bethany, Dhalwani, Nafeesa, Jones, Laney, Wojcik, Cezary, Peterson, Eric and Navar, Ann Marie (2024). Health System Variability in Lipid Management for Patients with Atherosclerotic Cardiovascular Disease: An Analysis from Cv-MOBIUS. American Heart Association's 2024 Scientific Sessions and the American Heart Association's 2024 Resuscitation Science Symposium, Chicago, IL United States, 16–18 November 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1161/circ.150.suppl_1.4145340 |
|
2022 Conference Publication Contribution of Clinical Trial Event Data by Data Source: Insights From the ADAPTABLE TrialRymer, Jennifer A., Mulder, Hillary, Wruck, Lisa M., Munoz, Daniel, Kripalani, Sunil, Effron, Mark B., Gupta, Kamal, Handberg, Eileen M., Jain, Sandeep, Girotra, Saket, Whittle, Jeffrey, Hess, Rachel, Benziger, Catherine, Knowlton, Kirk U., Curtis, Lesley, Roe, Matthew T., Hammill, Bradley G., Rothman, Russell, Harrington, Josephine, Hernandez, Adrian F. and Jones, William (2022). Contribution of Clinical Trial Event Data by Data Source: Insights From the ADAPTABLE Trial. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2022 Conference Publication Patient Differences in Prescription Patterns for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors When More Intensive Therapy is NeededEffron, Mark B., Kakkar, Anjali, Desrosiers, Greg, Velasco-Gonzalez, Cruz and Cooper-dehoff, Rhonda M. (2022). Patient Differences in Prescription Patterns for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors When More Intensive Therapy is Needed. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2022 Conference Publication Effect of Aspirin Dosing in Patients Treated With P2Y12 Inhibitors for Secondary Prevention of Cardiovascular EventsGirotra, Saket, Stebbins, Amanda, Wruck, Lisa M., Riley, Danielle, Kripalani, Sunil, Munoz, Daniel, Effron, Mark B., Gupta, Kamal, Whittle, Jeffrey, Benziger, Catherine, Zhou, Li, Farrehi, Peter M., Polonsky, Tamar S., Ahmad, Faraz S., Roe, Matthew T., Rothman, Russell, Harrington, Robert A., Hernandez, Adrian F. and Jones, William S. (2022). Effect of Aspirin Dosing in Patients Treated With P2Y12 Inhibitors for Secondary Prevention of Cardiovascular Events. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2022 Conference Publication Comparison of Enteric Coated Aspirin With Plain Aspirin on Effectiveness and Safety in the ADAPTABLE TrialEffron, Mark B., Sleem, Amber, Stebbins, Amanda, Wruck, Lisa M., Gravel, Guillaume, Munoz, Daniel, Re, Richard N., Gupta, Kamal, Pepine, Carl, Jain, Sandeep, Girotra, Saket, Whittle, Jeffrey, Benziger, Catherine, Farrehi, Peter M., Knowlton, Kirk U., Polonsky, Tamar S., Roe, Matthew T., Rothman, Russell T., Harrington, Robert A., Jones, William S. and Hernandez, Adrian F. (2022). Comparison of Enteric Coated Aspirin With Plain Aspirin on Effectiveness and Safety in the ADAPTABLE Trial. Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, Chicago Il, Nov 05-06, 2022. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2016 Conference Publication USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKINGSalianski, Olga, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Chandrasekhar, Jaya, Kini, Annapoorna, Rao, Sunil, Weintraub, William, Weiss, Sandra, Henry, Timothy, Kapadia, Samir, Poddar, Kanhaiya, DeFranco, Anthony, Muhlestein, J., Toma, Catalin, Effron, Mark, Keller, Stuart, Baker, Brian, Pocock, Stuart and Mehran, Roxana (2016). USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING. 65th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Apr 02-04, 2016. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(16)30185-1 |
|
2016 Conference Publication INCIDENCE, PREDICTORS AND IMPACT OF STROKE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES: RESULTS FROM THE PROMETHEUS REGISTRYGiustino, Gennaro, Baber, Usman, Sartori, Samantha, Aoi, Shunsuke, Aquino, Melissa, Chandrasekhar, Jaya, Weintraub, William, Rao, Sunil, Weiss, Sandra, Henry, Timothy, Kapadia, Samir, Poddar, Kanhaiya, DeFranco, Anthony, Muhlestein, J., Toma, Catalin, Effron, Mark, Keller, Stuart, Baker, Brian, Pocock, Stuart and Mehran, Roxana (2016). INCIDENCE, PREDICTORS AND IMPACT OF STROKE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES: RESULTS FROM THE PROMETHEUS REGISTRY. 65th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Apr 02-04, 2016. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(16)30049-3 |
|
2015 Conference Publication Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS StudyChandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Henry, Timothy D., Kini, Annapoorna, Kapadia, Samir, Rao, Sunil, Weiss, Sandra, Muhlestein, Joseph B., Poddar, Kanhaiya L., Baker, Brian A., Keller, Stuart Y., Effron, Mark B., Chao, Jennifer, Strauss, Craig E., DeFranco, Anthony, Weintraub, William and Mehran, Roxana (2015). Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study. 27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 11-15, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2015.08.234 |
|
2015 Conference Publication Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS StudyChandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, DeFranco, Anthony, Muhlestein, Joseph B., Weiss, Sandra, Henry, Timothy D., Effron, Mark B., Strauss, Craig E., Keller, Stuart Y., Baker, Brian A., Weintraub, William, Chao, Jennifer, Poddar, Kanhaiya L., Rao, Sunil, Kapadia, Samir, Kini, Annapoorna and Mehran, Roxana (2015). Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study. 27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 11-15, 2015. NEW YORK: ELSEVIER SCIENCE INC. |
|
2015 Conference Publication Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS StudyChandrasekhar, Jaya, Baber, Usman, Sartori, Samantha, Aquino, Melissa, Strauss, Craig E., Muhlestein, Joseph B., Weiss, Sandra, Effron, Mark B., Keller, Stuart Y., Baker, Brian A., Chao, Jennifer, Rao, Sunil, Kapadia, Samir, Poddar, Kanhaiya L., DeFranco, Anthony, Kini, Annapoorna, Weintraub, William, Henry, Timothy D. and Mehran, Roxana (2015). Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study. 27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 11-15, 2015. NEW YORK: ELSEVIER SCIENCE INC. |
|
2015 Conference Publication Clinical Outcomes Using Prasugrel or Ticagrelor Based On Physician Treatment Decisions In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Comparative Results Using Propensity Analysis Of A Payer DatabaseEffron, Mark B., Nair, Kavita V., Molife, Cliff, Keller, Stuart Y., Page, Robert L., Simeone, Jason, Murphy, Brian, Nordstrom, Beth L., Zhu, Yajun, McCollam, Patrick L. and Vetrovec, George W. (2015). Clinical Outcomes Using Prasugrel or Ticagrelor Based On Physician Treatment Decisions In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Comparative Results Using Propensity Analysis Of A Payer Database. 27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 11-15, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2015.08.184 |
|
2015 Conference Publication Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS CohortBaber, Usman, Chao, Jennifer, Chandrasekhar, Jaya, Sartori, Samantha, Aquino, Melissa, Kini, Annapoorna, Rao, Sunil, Weintraub, William, Weiss, Sandra, Strauss, Craig E., Kapadia, Samir, Henry, Timothy D., DeFranco, Anthony, Muhlestein, Joseph B., Toma, Catalin, Pocock, Stuart J., Keller, Stuart Y., Effron, Mark B., Baker, Brian A. and Mehran, Roxana (2015). Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS Cohort. 27th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), San Francisco Ca, Oct 11-15, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2015.08.503 |
|
2015 Conference Publication SELECTION OF PRASUGREL VERSUS CLOPIDOGREL AMONG MYOCARDIAL INFARCTION PATIENTS WITH HIGH VERSUS LOW PREDICTED MORTALITY AND BLEEDING RISKS: INSIGHTS FROM TRANSLATE-ACSVora, Amit, Peterson, Eric, McCoy, Lisa, Effron, Mark, Anstrom, Kevin, Faries, Douglas, Zettler, Marjorie, Fonarow, Gregg, Baker, Brian, Stone, Gregg and Wang, Tracy (2015). SELECTION OF PRASUGREL VERSUS CLOPIDOGREL AMONG MYOCARDIAL INFARCTION PATIENTS WITH HIGH VERSUS LOW PREDICTED MORTALITY AND BLEEDING RISKS: INSIGHTS FROM TRANSLATE-ACS. Scientific Session of the American-College-of-Cardiology (ACC), San Diego Ca, Mar 14-16, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(15)60107-3 |
|
2015 Conference Publication IMPACT OF PROTON PUMP INHIBITOR USE ON THE COMPARATIVE SAFETY AND EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL: INSIGHTS FROM TRANSLATE-ACSJackson, Larry R., Peterson, Eric, McCoy, Lisa, Ju, Christine, Zettler, Marjorie, Baker, Brian, Messenger, John, Faries, Douglas, Effron, Mark, Cohen, David and Wang, Tracy (2015). IMPACT OF PROTON PUMP INHIBITOR USE ON THE COMPARATIVE SAFETY AND EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL: INSIGHTS FROM TRANSLATE-ACS. Scientific Session of the American-College-of-Cardiology (ACC), San Diego Ca, Mar 14-16, 2015. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(15)60225-X |
|
2014 Conference Publication Safety and Effectiveness of Prasugrel vs. Clopidogrel in the Setting of Bivalirudin vs. Heparin Use: 30-day Results from TRANSLATE-ACSHenry, Timothy D., Peterson, Eric, Cohen, David, Ju, Christine, Stone, Gregg W., Messenger, John C., Fonarow, Gregg C., Effron, Mark B., Baker, Brian A., Zettler, Marjorie and Wang, Tracy Y. (2014). Safety and Effectiveness of Prasugrel vs. Clopidogrel in the Setting of Bivalirudin vs. Heparin Use: 30-day Results from TRANSLATE-ACS. 26th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Washington Dc, Sep 13-17, 2014. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jacc.2014.07.548 |
|
2014 Conference Publication EFFICACY AND SAFETY OF PRETREATMENT AONG CONTEMPORARY ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDYEffron, Mark B., Wang, Tracy, Fonarow, Gregg, Henry, Timothy, Zettler, Marjorie, Baker, Brian, McCoy, Lisa and Peterson, Eric (2014). EFFICACY AND SAFETY OF PRETREATMENT AONG CONTEMPORARY ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(14)60101-7 |
|
2014 Conference Publication DIFFERENTIAL USE BETWEEN PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ROUTINE PRACTICEEffron, Mark B., Molife, Cliff, Karkare, Swapna, Larmore, Cynthia, Zhu, Yajun, Lee, Won Chan, Frech-Tamas, Feride, Lieu, Hsiao and DeKoven, Mitch (2014). DIFFERENTIAL USE BETWEEN PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ROUTINE PRACTICE. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(14)60225-4 |
|
2014 Conference Publication TRIPLE THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: A COMPARISON OF CLOPIDOGREL VERSUS PRASUGREL FROM THE TRANSLATE-ACS STUDYJackson, Larry R., Zettler, Marjorie, Peterson, Eric, Ju, Christine, Effron, Mark, Messenger, John, Cohen, David, Stone, Gregg and Wang, Tracy (2014). TRIPLE THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: A COMPARISON OF CLOPIDOGREL VERSUS PRASUGREL FROM THE TRANSLATE-ACS STUDY. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(14)60026-7 |
|
2013 Conference Publication A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 StudyAnaiolillo, Dominick J., Curzen, Nicholas, Gurbel, Paul A., Vaitkus, Paul, Lipkin, Fred, Li, Wei, Jakubowski, Joseph A., Zettler, Marjorie, Effron, Mark B. and Trenk, Dietmar (2013). A Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 Study. Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association, Dallas Tx, Nov 16-17, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
